Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells

Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest cancers in the world. PDAC cells activate tumor-specific immune responses but simultaneously trigger a strong immunosuppression. We showed that PDAC cells produce high amount of chronic inflammatory mediators and PDAC tumors bui...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Karakhanova, Svetlana (VerfasserIn) , Link, Julia (VerfasserIn) , Heinrich, Moritz (VerfasserIn) , Shevchenko, Ivan (VerfasserIn) , Yang, Yuhui (VerfasserIn) , Hassenpflug, Matthias (VerfasserIn) , Ahn, Katharina von (VerfasserIn) , Maier, Caroline (VerfasserIn) , Umansky, Viktor (VerfasserIn) , Werner, Jens (VerfasserIn) , Bazhin, Alexandr V. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 Jan 2015
In: OncoImmunology
Year: 2015, Jahrgang: 4, Heft: 4, Pages: e998519
ISSN:2162-402X
DOI:10.1080/2162402X.2014.998519
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1080/2162402X.2014.998519
Volltext
Verfasserangaben:Svetlana Karakhanova, Julia Link, Moritz Heinrich, Ivan Shevchenko, Yuhui Yang, Matthias Hassenpflug, Henriette Bunge, Katharina von Ahn, Ramona Brecht, Andreas Mathes, Caroline Maier, Viktor Umansky, Jens Werner, Alexandr V. Bazhin

MARC

LEADER 00000caa a2200000 c 4500
001 1558996133
003 DE-627
005 20220813175514.0
007 cr uuu---uuuuu
008 170524s2015 xx |||||o 00| ||eng c
024 7 |a 10.1080/2162402X.2014.998519  |2 doi 
035 |a (DE-627)1558996133 
035 |a (DE-576)488996139 
035 |a (DE-599)BSZ488996139 
035 |a (OCoLC)1340975645 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Karakhanova, Svetlana  |e VerfasserIn  |0 (DE-588)1037188128  |0 (DE-627)752408259  |0 (DE-576)184019230  |4 aut 
245 1 0 |a Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer  |b importance of myeloid-derived suppressor cells  |c Svetlana Karakhanova, Julia Link, Moritz Heinrich, Ivan Shevchenko, Yuhui Yang, Matthias Hassenpflug, Henriette Bunge, Katharina von Ahn, Ramona Brecht, Andreas Mathes, Caroline Maier, Viktor Umansky, Jens Werner, Alexandr V. Bazhin 
264 1 |c 22 Jan 2015 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.05.2017 
520 |a Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest cancers in the world. PDAC cells activate tumor-specific immune responses but simultaneously trigger a strong immunosuppression. We showed that PDAC cells produce high amount of chronic inflammatory mediators and PDAC tumors build an immunosuppressive cytokine milieu, which correlates with tumor progression. We observed a low frequency of dendritic cells (DC) and a pronounced accumulation of macrophages and myeloid-derived suppressor cells (MDSC) in murine PDAC tumors. A strong accumulation of MDSC has also been demonstrated in the peripheral blood of resected PDAC patients. While DC and macrophages seem not to play a significant role in this PDAC model in the context of immunosuppression, MDSC are highly suppressive, and their accumulation is associated with an increase in intratumoral VEGF concentration during the PDAC progression. Application of the phosphodiesterase-5 inhibitor sildenafil led to a prolonged survival of PDAC-bearing female mice, which was due to the decrease in MDSC frequencies and in the systemic VEGF level. This led to a restoration of anticancer immune responses, manifested in the recovery of T lymphocyte functions and in an increase in the frequency of conventional CD4+ T cells in tumors and IFNγ level in serum of PDAC-bearing mice. Thus, MDSC are strongly involved in the PDAC-associated immunosuppression and that their depletion could create new approaches for therapy of PDAC. 
650 4 |a ARG-1, arginase-1 
650 4 |a DC, dendritic cells 
650 4 |a immune suppression 
650 4 |a MDSC 
650 4 |a MDSC, myeloid-derived suppressor cells 
650 4 |a NO, nitric oxide 
650 4 |a orthotopic Panc02 model 
650 4 |a pancreatic adenocarcinoma 
650 4 |a PDAC, pancreatic ductal adenocarcinoma 
650 4 |a TIL, tumor-infiltrating leukocytes 
650 4 |a Tregs, regulatory T cells 
700 1 |a Link, Julia  |d 1989-  |e VerfasserIn  |0 (DE-588)1071154192  |0 (DE-627)825611695  |0 (DE-576)432972277  |4 aut 
700 1 |a Heinrich, Moritz  |e VerfasserIn  |0 (DE-588)1126661848  |0 (DE-627)881250864  |0 (DE-576)484644114  |4 aut 
700 1 |a Shevchenko, Ivan  |d 1987-  |e VerfasserIn  |0 (DE-588)1036937577  |0 (DE-627)751519707  |0 (DE-576)389952389  |4 aut 
700 1 |a Yang, Yuhui  |d 1984-  |e VerfasserIn  |0 (DE-588)1025879805  |0 (DE-627)725386673  |0 (DE-576)370871022  |4 aut 
700 1 |a Hassenpflug, Matthias  |d 1979-  |e VerfasserIn  |0 (DE-588)143006827  |0 (DE-627)641429479  |0 (DE-576)334578043  |4 aut 
700 1 |a Ahn, Katharina von  |e VerfasserIn  |0 (DE-588)1076145612  |0 (DE-627)834477912  |0 (DE-576)44499811X  |4 aut 
700 1 |a Maier, Caroline  |e VerfasserIn  |4 aut 
700 1 |a Umansky, Viktor  |d 1955-  |e VerfasserIn  |0 (DE-588)102885756X  |0 (DE-627)731733207  |0 (DE-576)376300078  |4 aut 
700 1 |a Werner, Jens  |d 1966-  |e VerfasserIn  |0 (DE-588)120690764  |0 (DE-627)704926717  |0 (DE-576)292340249  |4 aut 
700 1 |a Bazhin, Alexandr V.  |e VerfasserIn  |0 (DE-588)1025289552  |0 (DE-627)721987710  |0 (DE-576)370168046  |4 aut 
773 0 8 |i Enthalten in  |t OncoImmunology  |d Abingdon : Taylor & Franics, 2012  |g 4(2015,4) Artikel-Nummer e998519, 14 Seiten  |h Online-Ressource  |w (DE-627)683365428  |w (DE-600)2645309-5  |w (DE-576)356728366  |x 2162-402X  |7 nnas  |a Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer importance of myeloid-derived suppressor cells 
773 1 8 |g volume:4  |g year:2015  |g number:4  |g pages:e998519  |g extent:14  |a Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer importance of myeloid-derived suppressor cells 
856 4 0 |u http://dx.doi.org/10.1080/2162402X.2014.998519  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20170524 
993 |a Article 
994 |a 2015 
998 |g 1025289552  |a Bazhin, Alexandr V.  |m 1025289552:Bazhin, Alexandr V.  |p 14  |y j 
998 |g 120690764  |a Werner, Jens  |m 120690764:Werner, Jens  |p 13 
998 |g 143006827  |a Hassenpflug, Matthias  |m 143006827:Hassenpflug, Matthias  |d 910000  |d 910200  |e 910000PH143006827  |e 910200PH143006827  |k 0/910000/  |k 1/910000/910200/  |p 6 
998 |g 1071154192  |a Link, Julia  |m 1071154192:Link, Julia  |d 910000  |d 910200  |e 910000PL1071154192  |e 910200PL1071154192  |k 0/910000/  |k 1/910000/910200/  |p 2 
998 |g 1037188128  |a Karakhanova, Svetlana  |m 1037188128:Karakhanova, Svetlana  |d 50000  |e 50000PK1037188128  |k 0/50000/  |p 1  |x j 
998 |g 102885756X  |a Umansky, Viktor  |m 102885756X:Umansky, Viktor  |d 60000  |d 61900  |d 140000  |e 60000PU102885756X  |e 61900PU102885756X  |e 140000PU102885756X  |k 0/60000/  |k 1/60000/61900/  |k 0/140000/  |p 12 
999 |a KXP-PPN1558996133  |e 2970215896 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"22 Jan 2015"}],"note":["Gesehen am 24.05.2017"],"name":{"displayForm":["Svetlana Karakhanova, Julia Link, Moritz Heinrich, Ivan Shevchenko, Yuhui Yang, Matthias Hassenpflug, Henriette Bunge, Katharina von Ahn, Ramona Brecht, Andreas Mathes, Caroline Maier, Viktor Umansky, Jens Werner, Alexandr V. Bazhin"]},"recId":"1558996133","title":[{"title_sort":"Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer","subtitle":"importance of myeloid-derived suppressor cells","title":"Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer"}],"relHost":[{"disp":"Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer importance of myeloid-derived suppressor cellsOncoImmunology","note":["Gesehen am 13.12.2022"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"OncoImmunology","title":"OncoImmunology"}],"language":["eng"],"origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedKey":"2012","publisher":"Taylor & Franics ; Landes Bioscience","dateIssuedDisp":"2012-"}],"titleAlt":[{"title":"Onco Immunology"}],"recId":"683365428","id":{"eki":["683365428"],"issn":["2162-402X"],"zdb":["2645309-5"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2012 -"],"part":{"volume":"4","year":"2015","extent":"14","issue":"4","pages":"e998519","text":"4(2015,4) Artikel-Nummer e998519, 14 Seiten"}}],"physDesc":[{"extent":"14 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1080/2162402X.2014.998519"],"eki":["1558996133"]},"language":["eng"],"person":[{"display":"Karakhanova, Svetlana","role":"aut","family":"Karakhanova","given":"Svetlana"},{"role":"aut","display":"Link, Julia","given":"Julia","family":"Link"},{"given":"Moritz","family":"Heinrich","role":"aut","display":"Heinrich, Moritz"},{"display":"Shevchenko, Ivan","role":"aut","family":"Shevchenko","given":"Ivan"},{"display":"Yang, Yuhui","role":"aut","family":"Yang","given":"Yuhui"},{"display":"Hassenpflug, Matthias","role":"aut","family":"Hassenpflug","given":"Matthias"},{"role":"aut","display":"Ahn, Katharina von","given":"Katharina von","family":"Ahn"},{"given":"Caroline","family":"Maier","role":"aut","display":"Maier, Caroline"},{"role":"aut","display":"Umansky, Viktor","given":"Viktor","family":"Umansky"},{"role":"aut","display":"Werner, Jens","given":"Jens","family":"Werner"},{"role":"aut","display":"Bazhin, Alexandr V.","given":"Alexandr V.","family":"Bazhin"}]} 
SRT |a KARAKHANOVCHARACTERI2220